TENX
TENAX THERAPEUTICS, INC.
Company overview
- Market capitalization
- $69.23M
- Employees
- 14
- Latest publication
- 2026-09-29
About TENAX THERAPEUTICS, INC.
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 2,000USD | 0USD | 0USD |
| Research Development | 11,539,000USD | 10,540,000USD | 10,328,000USD | 6,121,000USD | 5,683,000USD | 4,593,630USD | 3,112,085USD | 2,327,000USD |
| Selling General Administrative | 5,034,000USD | 5,909,000USD | 6,478,000USD | 5,671,000USD | 5,655,000USD | 2,701,141USD | 1,506,796USD | 1,344,000USD |
| Total Operating Expenses | 16,573,000USD | 16,449,000USD | 16,806,000USD | 11,792,000USD | 11,338,000USD | 7,294,772USD | -4,618,881USD | 3,671,000USD |
| Operating Income | -16,573,000USD | -16,449,000USD | -16,806,000USD | -11,792,000USD | -11,338,000USD | -7,294,772USD | 4,618,881USD | -3,671,000USD |
| Interest Income | 861,000USD | 918,000USD | 1,017,000USD | 954,000USD | 930,000USD | 1,026,943USD | 664,724USD | 104,883USD |
| Net Interest Income | 861,000USD | 918,000USD | 1,017,000USD | 954,000USD | 930,000USD | 1,027,408USD | 658,412USD | 95,694USD |
| Income Before Tax | -15,716,000USD | -15,540,000USD | -15,804,000USD | -10,847,000USD | -10,408,000USD | -6,267,018USD | -3,960,469USD | -3,575,000USD |
| Net Income | -15,716,000USD | -15,540,000USD | -15,804,000USD | -10,847,000USD | -10,408,000USD | -6,267,018USD | -3,960,469USD | -3,575,000USD |
| Net Income From Continuing Ops | -15,716,000USD | -15,540,000USD | -15,804,000USD | -10,847,000USD | -10,408,000USD | -6,267,018USD | -3,960,469USD | -3,575,673USD |
| Ebitda | -16,573,000USD | -15,540,000USD | -15,804,000USD | -10,847,000USD | -10,408,000USD | -6,267,019USD | -3,954,157USD | -3,566,000USD |
| Total Other Income Expense Net | 857,000USD | 909,000USD | 1,002,000USD | 945,000USD | 930,000USD | 1,027,754USD | -8,579,350USD | 96,000USD |
| Interest Expense | — | 0USD | 0USD | 0USD | 0USD | 464USD | 6,312USD | 9,189USD |
| Ebit | — | — | — | -11,792,000USD | -11,338,000USD | -6,312,018USD | -3,952,265USD | -3,566,488USD |
| Cost Of Revenue | — | — | — | — | — | 1,000USD | — | 1,000USD |
| Gross Profit | — | — | — | — | — | 1,000USD | — | -1,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 1USD | — | 1,000USD |
| Depreciation And Amortization | — | — | — | — | — | 44,999USD | -1,892USD | 1,000USD |
| Reconciled Depreciation | — | — | — | — | — | 0USD | 0USD | 0USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | -9,237,762USD | — |
| Income Tax Expense | — | — | — | — | — | — | 3,960,469USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 32,672,000USD | 12,709,000USD | 3,229,000USD | 5,377,412USD | 25,147,394USD | 4,560,724USD | 3,471,153USD | 1,239,300USD |
| Selling General Administrative | 23,713,000USD | 6,785,000USD | 5,005,000USD | 5,675,231USD | 7,580,847USD | 5,307,206USD | 5,084,111USD | 5,653,980USD |
| Total Operating Expenses | 56,385,000USD | 19,494,000USD | 8,234,000USD | 11,052,643USD | 32,728,241USD | 9,753,182USD | 8,555,264USD | 6,893,280USD |
| Operating Income | -56,385,000USD | -19,494,000USD | -8,234,000USD | -11,052,643USD | -32,728,241USD | -9,867,930USD | -8,555,264USD | -6,893,280USD |
| Interest Income | 3,819,000USD | 1,914,000USD | 484,000USD | — | — | — | — | — |
| Interest Expense | 0USD | 23,000USD | 23,967USD | 4,443USD | 949USD | 1,627USD | 0USD | 0USD |
| Net Interest Income | 3,819,000USD | 1,891,000USD | 345,064USD | -4,443USD | -949USD | -1,627USD | — | — |
| Income Before Tax | -52,599,000USD | -17,602,000USD | -7,711,000USD | -11,047,895USD | -32,474,358USD | -9,851,391USD | -8,394,363USD | -6,813,445USD |
| Net Income | -52,599,000USD | -17,602,000USD | -7,711,000USD | -11,047,895USD | -32,474,358USD | -9,851,391USD | -8,394,363USD | -6,813,445USD |
| Net Income From Continuing Ops | -52,599,000USD | -17,602,000USD | -7,033,875USD | -11,047,895USD | -32,474,358USD | -9,851,391USD | -8,394,363USD | -6,813,445USD |
| Ebitda | -56,385,000USD | -17,579,000USD | -7,679,000USD | -10,930,120USD | -32,364,427USD | -9,735,012USD | -8,550,247USD | -6,884,264USD |
| Total Other Income Expense Net | 3,786,000USD | 1,892,000USD | 523,000USD | 4,748USD | 253,883USD | 16,539USD | 160,901USD | 79,835USD |
| Ebit | — | -17,625,000USD | -7,687,000USD | -11,043,452USD | -32,473,409USD | -9,849,760USD | -8,555,264USD | -6,893,279USD |
| Depreciation And Amortization | — | 46,000USD | 8,000USD | 113,332USD | 108,982USD | 114,748USD | 5,017USD | 9,015USD |
| Reconciled Depreciation | — | 0USD | 32,066USD | 113,332USD | 108,982USD | 114,748USD | 107,279USD | 9,016USD |
| Cost Of Revenue | — | — | 7,570USD | 113,332USD | 108,982USD | 114,748USD | 107,279USD | 9,015USD |
| Gross Profit | — | — | -7,570USD | -113,332USD | -108,982USD | -114,748USD | -107,279USD | -9,015USD |
| Selling And Marketing Expenses | — | — | 7,570USD | — | — | — | — | — |
| Income Tax Expense | — | — | 1USD | -4,748USD | 255,781USD | 19,793USD | -64,581USD | -79,835USD |
| Net Income Applicable To Common Shares | — | — | — | — | -32,474,358USD | -9,851,391USD | -8,394,363USD | -14,144,049USD |
| Non Operating Income Net Other | — | — | — | — | — | 18,166USD | 160,901USD | 79,835USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 121,663,000USD | 123,178,000USD | 104,227,000USD | 102,810,000USD | 105,857,000USD | 112,059,000USD | 96,686,000USD | 99,784,745USD |
| Cash And Equivalents | 117,976,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 121,663,000USD | 123,178,000USD | 104,227,000USD | 102,810,000USD | 105,857,000USD | 112,059,000USD | 96,686,000USD | 99,783,628USD |
| Other Current Assets | 272,000USD | 4,423,000USD | 6,662,000USD | 3,441,000USD | 395,000USD | 612,000USD | 1,835,000USD | 1,472,710USD |
| Total Liabilities | 8,073,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 8,073,000USD | 8,486,000USD | 7,156,000USD | 6,599,000USD | 2,527,000USD | 2,768,000USD | 4,693,000USD | 2,561,690USD |
| Other Current Liabilities | 1,278,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 113,590,000USD | 114,692,000USD | 97,071,000USD | 96,211,000USD | 103,330,000USD | 109,291,000USD | 91,993,000USD | 97,223,055USD |
| Total Equity Including Noncontrolling Interest | 113,590,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 6,795,000USD | 6,346,000USD | 6,041,000USD | 5,608,000USD | 562,000USD | 1,839,000USD | 3,157,000USD | 1,584,145USD |
| Common Stock | 3,000USD | 2,000USD | 1,000USD | 1,000USD | — | — | — | 341USD |
| Retained Earnings | -400,973,000USD | -383,170,000USD | -367,454,000USD | -351,914,000USD | -336,110,000USD | -325,263,000USD | -314,855,000USD | -308,587,735USD |
| Total Liab | — | 8,486,000USD | 7,156,000USD | 6,599,000USD | 2,527,000USD | 2,768,000USD | 4,693,000USD | 2,561,690USD |
| Other Current Liab | — | 2,140,000USD | 1,115,000USD | 991,000USD | 1,965,000USD | 929,000USD | 1,536,000USD | 977,545USD |
| Capital Stock | — | 2,000USD | 1,000USD | 1,000USD | 0USD | 0USD | 0USD | 341USD |
| Cash | — | 118,755,000USD | 97,565,000USD | 99,369,000USD | 105,462,000USD | 111,447,000USD | 94,851,000USD | 98,310,918USD |
| Cash And Short Term Investments | — | 118,755,000USD | 97,565,000USD | 99,369,000USD | 105,462,000USD | 111,447,000USD | 94,851,000USD | 98,310,918USD |
| Net Debt | — | -118,755,000USD | -97,565,000USD | -99,369,000USD | -105,462,000USD | -111,447,000USD | -94,851,000USD | -98,310,918USD |
| Common Stock Shares Outstanding | — | 45,226,328shares | 39,217,244shares | 39,741,404shares | 39,572,177shares | 36,584,920shares | 15,271,705shares | 21,161,143shares |
| Non Current Assets Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 1,117USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Working Capital | — | 114,692,000USD | 97,071,000USD | 96,211,000USD | 103,330,000USD | 109,291,000USD | 91,993,000USD | 97,221,938USD |
| Unclassified Equity | — | 497,858,000USD | 464,523,000USD | 448,123,000USD | 439,440,000USD | 434,554,000USD | 406,848,000USD | 405,810,108USD |
| Non Currrent Assets Other | — | — | — | — | — | — | — | 1,117USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 104,227,000USD | 96,686,000USD | 11,684,627USD | 3,404,709USD | 5,992,235USD | 6,868,691USD | 6,365,271USD | 13,337,200USD |
| Other Current Assets | 6,662,000USD | 1,835,000USD | 1,891,380USD | 1,084,783USD | 105,078USD | 82,578USD | 780,952USD | 458,286USD |
| Total Liab | 7,156,000USD | 4,693,000USD | 3,586,520USD | 1,911,968USD | 1,747,567USD | 2,243,129USD | 2,592,774USD | 1,565,669USD |
| Total Stockholder Equity | 97,071,000USD | 91,993,000USD | 8,098,107USD | 1,492,741USD | 4,244,668USD | 4,625,562USD | 3,772,497USD | 11,771,531USD |
| Other Current Liab | 1,115,000USD | 1,536,000USD | 1,012,468USD | 655,652USD | 597,148USD | 1,180,237USD | 759,988USD | 815,855USD |
| Common Stock | 1,000USD | — | 30USD | 4,584USD | 2,521USD | 1,262USD | 674USD | 379USD |
| Capital Stock | 1,000USD | 0USD | 30USD | 4,584USD | 2,521USD | 1,262USD | 678USD | 664USD |
| Retained Earnings | -367,454,000USD | -314,855,000USD | -297,252,753USD | -289,542,080USD | -278,494,185USD | -246,019,827USD | -236,168,436USD | -227,801,743USD |
| Cash | 97,565,000USD | 94,851,000USD | 9,792,130USD | 2,123,682USD | 5,583,922USD | 6,250,241USD | 4,905,993USD | 12,367,321USD |
| Cash And Short Term Investments | 97,565,000USD | 94,851,000USD | 9,792,130USD | 2,123,682USD | 5,583,922USD | 6,712,928USD | 5,399,877USD | 12,861,954USD |
| Total Current Assets | 104,227,000USD | 96,686,000USD | 11,683,510USD | 3,208,465USD | 5,689,000USD | 6,795,506USD | 6,180,829USD | 13,320,240USD |
| Total Current Liabilities | 7,156,000USD | 4,693,000USD | 3,586,520USD | 1,847,772USD | 1,563,978USD | 2,118,963USD | 2,532,395USD | 1,565,669USD |
| Net Debt | -97,565,000USD | -94,851,000USD | -9,291,227USD | -1,315,791USD | -5,293,141USD | -5,945,205USD | -4,734,261USD | -12,367,321USD |
| Accounts Payable | 6,041,000USD | 3,157,000USD | 2,073,149USD | 448,425USD | 859,638USD | 757,856USD | 1,661,054USD | 749,814USD |
| Common Stock Shares Outstanding | 39,217,244shares | 15,271,705shares | 248,447shares | 18,391shares | 12,860shares | 4,635shares | 3,872shares | 915shares |
| Non Current Assets Total | 0USD | 0USD | 1,117USD | 196,244USD | 303,235USD | 73,185USD | 184,442USD | 16,960USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 64,196USD | 183,589USD | 124,166USD | 60,379USD | 749,814USD |
| Net Working Capital | 97,071,000USD | 91,993,000USD | 8,096,990USD | 1,360,693USD | 4,125,022USD | 4,676,543USD | 3,648,434USD | 11,754,571USD |
| Unclassified Equity | 464,523,000USD | 406,848,000USD | 305,350,800USD | 291,025,653USD | 282,733,811USD | 250,642,935USD | 239,939,123USD | 239,571,715USD |
| Current Deferred Revenue | — | — | 1USD | — | — | — | — | — |
| Short Term Debt | — | — | 500,903USD | 743,695USD | 107,192USD | 180,870USD | 111,353USD | — |
| Short Long Term Debt | — | — | 500,903USD | 624,302USD | — | 120,491USD | — | — |
| Short Long Term Debt Total | — | — | 500,903USD | 807,891USD | 290,781USD | 305,036USD | 171,732USD | — |
| Property Plant Equipment Net | — | — | 0USD | 186,692USD | 294,800USD | 64,750USD | 176,007USD | 8,525USD |
| Property Plant Equipment Gross | — | — | 0USD | 186,692USD | 294,800USD | 5,972USD | 176,007USD | 8,525USD |
| Non Currrent Assets Other | — | — | 1,117USD | 9,552USD | 8,435USD | 8,435USD | 8,435USD | 8,435USD |
| Other Assets | — | — | — | — | 8,435USD | 8,435USD | 8,435USD | 8,435USD |
| Short Term Investments | — | — | — | — | 0USD | 462,687USD | 493,884USD | 494,633USD |
| Net Tangible Assets | — | — | — | — | 4,244,668USD | 4,625,562USD | 3,772,493USD | 11,771,246USD |
| Long Term Debt | — | — | — | — | — | 124,166USD | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | -70USD | 458USD | 516USD |
| Non Current Liabilities Other | — | — | — | — | — | — | 60,379USD | — |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Net Receivables | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -15,716,000USD | 37,059,000USD | -15,804,000USD | -10,847,000USD | -10,408,000USD | -6,267,018USD | -3,960,469USD | -3,575,000USD |
| Stock Based Compensation | 2,838,000USD | -14,373,000USD | 5,622,000USD | 4,609,000USD | 4,142,000USD | 1,125,000USD | 14,000USD | 22,000USD |
| Other Non Cash Items | 15,716,000USD | -33,436,000USD | 5,622,000USD | 4,609,000USD | 4,142,000USD | 969,097USD | 20,900USD | 9,000USD |
| Change In Working Capital | 3,569,000USD | -2,665,000USD | 1,026,999USD | -25,000USD | -701,000USD | 1,770,888USD | 852,271USD | 513,000USD |
| Total Cash From Operating Activities | -9,309,000USD | -13,415,000USD | -9,155,000USD | -6,263,000USD | -6,967,000USD | -3,527,033USD | -3,087,298USD | -3,031,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -3USD | -2USD | -1USD |
| Free Cash Flow | -9,309,000USD | -13,415,000USD | -9,155,000USD | -6,263,000USD | -6,967,000USD | -3,527,030USD | -3,087,300USD | -3,031,000USD |
| Total Cash From Financing Activities | 30,499,000USD | 11,611,000USD | 3,062,000USD | 278,000USD | 23,563,000USD | 67,245USD | 92,014,201USD | -134,000USD |
| Change In Cash | 21,190,000USD | -1,804,000USD | -6,093,000USD | -5,985,000USD | 16,596,000USD | -3,459,918USD | 88,926,903USD | -3,165,000USD |
| Begin Period Cash Flow | 97,565,000USD | 99,369,000USD | 105,462,000USD | 111,447,000USD | 94,851,000USD | 98,310,918USD | 9,384,015USD | 12,549,000USD |
| End Period Cash Flow | 118,755,000USD | 97,565,000USD | 99,369,000USD | 105,462,000USD | 111,447,000USD | 94,851,000USD | 98,310,918USD | 9,384,000USD |
| Unclassified Operating Cash Flow | -15,716,000USD | — | -5,621,999USD | -4,609,000USD | -4,142,000USD | -1,125,000USD | — | — |
| Change To Account Receivables | — | -1,222,776USD | 1,222,776USD | -1,224,000USD | 1,224USD | -360,670USD | -240,931USD | 677,601USD |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | -97USD | -279,000USD | — |
| Other Cashflows From Financing Activities | — | 11,611,000USD | 3,062,000USD | — | 23,563,000USD | 67,342USD | 681,480USD | -134USD |
| Investments | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Depreciation | — | — | — | — | — | 0USD | 0USD | 1,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | — | 91,952,263USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -52,599,000USD | -17,602,000USD | -7,711,000USD | -11,047,895USD | -32,474,358USD | -9,851,391USD | -8,394,363USD | -14,144,049USD |
| Stock Based Compensation | 19,163,000USD | 1,125,000USD | 191,000USD | 365USD | 774USD | 353USD | 271USD | 190,083USD |
| Other Non Cash Items | 19,163,000USD | 23,000USD | 25,000USD | 366,856USD | 22,119,261USD | 361,342USD | 270,508USD | 7,430,966USD |
| Change In Working Capital | -2,364,000USD | 1,643,000USD | 1,583,000USD | -1,445,166USD | -610,088USD | 102,445USD | 460,399USD | 606,752USD |
| Total Cash From Operating Activities | -35,800,000USD | -14,811,000USD | -5,904,000USD | -12,012,873USD | -10,856,203USD | -9,272,856USD | -7,556,177USD | -5,499,461USD |
| Capital Expenditures | 0USD | 0USD | -2,843USD | -2,327USD | -5,252USD | -3,490USD | -3,573USD | -7,595USD |
| Free Cash Flow | -35,800,000USD | -14,811,000USD | -5,904,000USD | -12,015,200USD | -10,861,455USD | -9,276,346USD | -7,559,750USD | -5,507,056USD |
| Net Borrowings | 0USD | -501,000USD | -624,000USD | 0USD | 0USD | 244,657USD | 244,657USD | 244,657USD |
| Total Cash From Financing Activities | 38,514,000USD | 99,870,000USD | 13,569,000USD | 8,554,956USD | 9,737,275USD | 10,596,995USD | 96,500USD | 8,907,174USD |
| Change In Cash | 2,714,000USD | 85,059,000USD | 7,668,000USD | -3,460,240USD | -666,319USD | 1,344,248USD | -7,461,328USD | 10,762,511USD |
| Begin Period Cash Flow | 94,851,000USD | 9,792,000USD | 2,124,000USD | 5,583,922USD | 6,250,241USD | 4,905,993USD | 12,367,321USD | 1,604,810USD |
| End Period Cash Flow | 97,565,000USD | 94,851,000USD | 9,792,000USD | 2,123,682USD | 5,583,922USD | 6,250,241USD | 4,905,993USD | 12,367,321USD |
| Other Cashflows From Financing Activities | 38,514,000USD | 100,371,000USD | 14,193,000USD | 7,930,654USD | 544,651USD | 1,693,161USD | 96,500USD | 25,144,952USD |
| Unclassified Operating Cash Flow | -19,163,000USD | — | — | — | — | — | — | — |
| Depreciation | — | 0USD | 8,000USD | 113,332USD | 108,982USD | 114,748USD | 107,279USD | 9,016USD |
| Change To Account Receivables | — | 58,000USD | -306,000USD | -980,822USD | -22,500USD | 698,374USD | -322,666USD | -122,605USD |
| Investments | — | 0USD | 6,843USD | -2,323USD | 457,861USD | 23,599USD | 1,923USD | 7,362,393USD |
| Change To Inventory | — | — | 305,694USD | — | 544,589USD | 535,550USD | -883,042USD | -729,357USD |
| Total Cashflows From Investing Activities | — | — | 3,000USD | -2,323USD | 452,609USD | 20,109USD | -1,651USD | 7,354,798USD |
| Other Cashflows From Investing Activities | — | — | 3,000USD | — | 458USD | 24USD | 2USD | 7,362USD |
| Change To Liabilities | — | — | — | — | -544,589USD | -535,550USD | 783,065USD | 729,357USD |
| Issuance Of Capital Stock | — | — | — | — | 9,192,624USD | 8,659,177USD | 2,130,005USD | 8,907,174USD |
| Sale Purchase Of Stock | — | — | — | — | — | 10,352,338USD | 96,500USD | 8,907,174USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 1,344,248USD | -7,461,328USD | 10,762,511USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -1,693,161USD | — | -18,059,005USD |
| Dividends Paid | — | — | — | — | — | — | — | -7,330,604USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.